Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A38989 | 9341062 | Ann Intern Med | The generalist/cardiovascular specialist: a proposal for a new training track. | 1997 | Details |
| A42206 | 35229410 | J Occup Health | Differences in cardiovascular risk levels between cleaning staff and hotel housekeepers. | 2022 | Details |
| A42207 | 35229393 | Hepatol Res | Atherosclerotic cardiovascular disease in non-metabolic nonalcoholic fatty liver disease. | 2022 | Details |
| A42214 | 35199660 | Curr Opin Clin Nutr Metab Care | Maternal weight and gestational diabetes impacts on child health. | 2022 | Details |
| A42215 | 35195252 | Biochem J | FoxO transcription factors in mitochondrial homeostasis. | 2022 | Details |
| A42234 | 35146047 | Open Forum Infect Dis | Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. | 2022 | Details |
| A42242 | 35118020 | J Lipid Atheroscler | Metabolism and Health Impacts of Dietary Sugars. | 2022 | Details |
| A42252 | 35092337 | Liver Int | Meaning of non-overlapping patients between the MAFLD and NAFLD definitions. | 2022 | Details |
| A42259 | 35062229 | Viruses | Pandemics of the 21st Century: The Risk Factor for Obese People. | 2021 | Details |
| A42261 | 35047117 | World J Diabetes | Omics era in type 2 diabetes: From childhood to adulthood. | 2021 | Details |
| A42274 | 35022960 | Mol Cell Biochem | Autophagy: a molecular switch to regulate adipogenesis and lipolysis. | 2022 | Details |
| A42288 | 34966660 | J Clin Transl Hepatol | Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease. | 2021 | Details |
| A42299 | 34931915 | Expert Rev Cardiovasc Ther | Serum uric acid: a mediator of cardio-reno-metabolic diseases. | 2021 | Details |
| A42309 | 34911389 | J Investig Med High Impact Case Rep | Overlap of Psoriatic Arthritis and Dermatomyositis. | 2021 | Details |
| A42314 | 34897733 | JPEN J Parenter Enteral Nutr | Case presentation and panel discussion: Cardiometabolic risk mitigation. | 2021 | Details |
| A42317 | 34887111 | Clin Investig Arterioscler | Bempedoic acid as a PPARα activator: new perspectives for hepatic steatosis treatment in a female rat experimental model. | 2021 | Details |
| A42344 | 34809444 | Circ Res | Posttranscriptional Regulation of the Human LDL Receptor by the U2-Spliceosome. | 2021 | Details |
| A42353 | 34779503 | Mol Med Rep | Efferocytosis in multisystem diseases (Review). | 2021 | Details |
| A42360 | 34766515 | Physiol Genomics | Systems genetics analysis defines importance of TMEM43/LUMA for cardiac- and metabolic-related pathways. | 2021 | Details |
| A42362 | 34764874 | Front Pharmacol | Carnitine Palmitoyltransferase System: A New Target for Anti-Inflammatory and Anticancer Therapy? | 2021 | Details |
| A42369 | 34748894 | J Hepatol | Reply to: "NAFLD vs. MAFLD - It is not the name but the disease that decides the outcome in fatty liver". | 2021 | Details |
| A42373 | 34741325 | Aliment Pharmacol Ther | Editorial: statin use in patients with NAFLD-safety concerns, decreased awareness or both? | 2021 | Details |
| A42379 | 34730107 | Gut Liver | Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease. | 2021 | Details |
| A42382 | 34724297 | Hepatol Res | Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease. | 2021 | Details |
| A42383 | 34724294 | Hepatol Res | Metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease: Which can better identify the populations with a high risk of cardiovascular disease? | 2021 | Details |
| A42386 | 34704503 | Crit Rev Food Sci Nutr | Effects and mechanisms of tea on obesity. | 2021 | Details |
| A42387 | 34699206 | J Nat Prod | Hypocholesterolemic Efficacy of Secoisolariciresinol Diglucoside and Its Polymer in Rat. | 2021 | Details |
| A42389 | 34698347 | Clin Infect Dis | Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection. | 2022 | Details |
| A42390 | 34697893 | J Dig Dis | Multidisciplinary participation: The key to a cure for non-alcoholic fatty liver disease. | 2021 | Details |
| A42396 | 34674606 | Gut Microbes | Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases? | 2022 | Details |
| A42402 | 34633856 | Annu Rev Nutr | Microbial Flavonoid Metabolism: A Cardiometabolic Disease Perspective. | 2021 | Details |
| A42405 | 34626045 | Liver Transpl | A Meta-Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients. | 2021 | Details |
| A42408 | 34617616 | Clin Endocrinol (Oxf) | Long-term health outcomes in young women with polycystic ovary syndrome: A narrative review. | 2021 | Details |
| A42427 | 34555344 | Lancet Gastroenterol Hepatol | The challenge of cardiovascular prevention in NAFLD. | 2021 | Details |
| A42430 | 34542351 | Crit Rev Food Sci Nutr | Branched chain amino acids-friend or foe in the control of energy substrate turnover and insulin sensitivity? | 2021 | Details |
| A42434 | 34530064 | J Hepatol | NAFLD vs. MAFLD - It is not the name but the disease that decides the outcome in fatty liver. | 2021 | Details |
| A42439 | 34519532 | mSystems | Gut Metabolites Are More Predictive of Disease and Cohoused States than Gut Bacterial Features in a Polycystic Ovary Syndrome-Like Mouse Model. | 2021 | Details |
| A42446 | 34509980 | Gut | Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is needed. | 2021 | Details |
| A42460 | 34476661 | Dig Dis Sci | Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B. | 2021 | Details |
| A42462 | 34474907 | Am J Cardiol | Independent Association of Fatty Liver Index With Left Ventricular Diastolic Dysfunction in Subjects Without Medication. | 2021 | Details |
| A42477 | 34436472 | Metabolites | The Role of Gut Microbiota and Its Produced Metabolites in Obesity, Dyslipidemia, Adipocyte Dysfunction, and Its Interventions. | 2021 | Details |
| A42479 | 34427594 | JAMA | Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. | 2021 | Details |
| A42481 | 34422393 | J Gastrointest Oncol | A discussion of the gut microbiome's development, determinants, and dysbiosis in cancers of the esophagus and stomach. | 2021 | Details |
| A42484 | 34409847 | Antioxid Redox Signal | Insufficient S-Sulfhydration of Methylenetetrahydrofolate Reductase Contributes to the Progress of Hyperhomocysteinemia. | 2021 | Details |
| A42491 | 34390271 | Semin Dial | The relationship between hepatic fibrosis and arterial stiffness in hemodialysis patients. | 2021 | Details |
| A42518 | 34305616 | Front Pharmacol | Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota. | 2021 | Details |
| A42553 | 34172646 | Transplantation | Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients. | 2022 | Details |
| A42556 | 34165872 | Liver Transpl | Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long-Term Survival. | 2021 | Details |
| A42571 | 34142426 | Diabetes Obes Metab | Sodium-glucose cotransporter-2 inhibitors for type 2 diabetes mellitus in adults: An overview of 46 systematic reviews. | 2021 | Details |
| A42574 | 34133256 | Expert Rev Mol Diagn | Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved : a systematic review. | 2021 | Details |
| A42586 | 34105827 | J Gastroenterol Hepatol | Liver-heart connection in diabetes mellitus. | 2021 | Details |
| A42598 | 34070749 | Int J Mol Sci | Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis. | 2021 | Details |
| A42601 | 34049381 | J Clin Gastroenterol | Statins and Cancer Mortality in NAFLD: Is it Too Early to Rejoice? | 2021 | Details |
| A42607 | 34035697 | Gastroenterol Hepatol (N Y) | Smoking and Liver Disease. | 2020 | Details |
| A42609 | 34033033 | MMW Fortschr Med | 2021 | Details | |
| A42614 | 34015974 | Expert Rev Clin Pharmacol | Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome. | 2021 | Details |
| A42620 | 33989632 | Metabolism | Long-term statin treatment for hepatic fibrosis in patients with nonalcoholic fatty liver disease: Is it time to give the emperor a statin robe? | 2021 | Details |
| A42624 | 33983128 | Interact J Med Res | Relevance of Anthropometric Measurements in a Multiethnic Obesity Cohort: Observational Study. | 2021 | Details |
| A42630 | 33961704 | Aliment Pharmacol Ther | Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non-alcoholic fatty liver disease-simply associated or more complicated? | 2021 | Details |
| A42631 | 33961702 | Aliment Pharmacol Ther | Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non-alcoholic fatty liver disease-simply associated or more complicated? Authors' reply. | 2021 | Details |
| A42653 | 33880928 | J Am Heart Assoc | Hepatic Steatosis in Patients With Single Ventricle and a Fontan Circulation. | 2021 | Details |
| A42669 | 33847140 | J Am Heart Assoc | The Liver and the Cardiovascular System: Two of a Kind? | 2021 | Details |
| A42672 | 33827290 | Angiology | The Impact of Ranolazine Treatment on Liver Tests in Patients With Coronary Artery Disease and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42693 | 33746439 | J Clin Exp Hepatol | Nonalcoholic Fatty Liver Disease: Lessons Learnt in the Last Five Years. | 2020 | Details |
| A42696 | 33739235 | Crit Rev Clin Lab Sci | Potential value and impact of data mining and machine learning in clinical diagnostics. | 2021 | Details |
| A42717 | 33654016 | Curr Opin Gastroenterol | Statins for treatment of chronic liver disease. | 2021 | Details |
| A42733 | 33610759 | Clin Gastroenterol Hepatol | MAFLD and Cardiovascular Events: What Does the Evidence Show? | 2021 | Details |
| A42749 | 33586126 | Am J Clin Dermatol | Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges. | 2021 | Details |
| A42758 | 33561215 | J Nutr | Associations of Serum Fatty Acid Proportions with Obesity, Insulin Resistance, Blood Pressure, and Fatty Liver: The Cardiovascular Risk in Young Finns Study. | 2021 | Details |
| A42760 | 33552481 | Clin Liver Dis (Hoboken) | Nonalcoholic Fatty Liver Disease and Cardiovascular Disease. | 2021 | Details |
| A42770 | 33525643 | Nutrients | The Marine Microalga, Tisochrysis lutea, Protects against Metabolic Disorders Associated with Metabolic Syndrome and Obesity. | 2021 | Details |
| A42775 | 33509738 | Dig Liver Dis | Reply to: "Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?" | 2021 | Details |
| A42776 | 33508742 | Redox Biol | Long non-coding RNA Meg3 deficiency impairs glucose homeostasis and insulin signaling by inducing cellular senescence of hepatic endothelium in obesity. | 2021 | Details |
| A42780 | 33497712 | Metabolism | Role of the gut microbiota in type 2 diabetes and related diseases. | 2021 | Details |
| A42783 | 33485968 | J Hepatol | Hypertension in NAFLD: An uncontrolled burden. | 2021 | Details |
| A42786 | 33483258 | Dig Liver Dis | Assessment of hepatic fibrosis in MAFLD: A new player in the evaluation of residual cardiovascular risk? | 2021 | Details |
| A42787 | 33479538 | Nat Rev Endocrinol | Global pandemics interconnected - obesity, impaired metabolic health and COVID-19. | 2021 | Details |
| A42813 | 33378945 | Biomed Pharmacother | A novel quantitative assay for analysis of GLUT4 translocation using high content screening. | 2020 | Details |
| A42836 | 33337742 | Clin Obstet Gynecol | Polycystic Ovarian Syndrome: Impact on Adult and Fetal Health. | 2021 | Details |
| A42849 | 33297754 | Arterioscler Thromb Vasc Biol | The Dynamic Platelet Transcriptome in Obesity and Weight Loss. | 2020 | Details |
| A42855 | 33280201 | Liver Int | Microalbuminuria in NAFLD patients: The impact of cardiovascular system. | 2020 | Details |
| A42857 | 33280151 | Hepatology | NAFLD and Cardiometabolic Risk Factors: The Liver Fibrosis Trajectory Through the Lens of Biological Interactions. | 2021 | Details |
| A42858 | 33277657 | J Clin Endocrinol Metab | Elevated Circulating Glutamate Is Associated With Subclinical Atherosclerosis Independently of Established Risk Markers: A Cross-Sectional Study. | 2021 | Details |
| A42863 | 33259630 | Toxicol Sci | Gestational Cd Exposure in the CD-1 Mouse Induces Sex-Specific Hepatic Insulin Insensitivity, Obesity, and Metabolic Syndrome in Adult Female Offspring. | 2020 | Details |
| A42875 | 33247713 | Endocr Rev | Metabolic Consequences of Solid Organ Transplantation. | 2021 | Details |
| A42889 | 33189580 | Can J Diabetes | Practical Considerations and Rationale for Glucagon-Like Peptide-1 Receptor Agonist Plus Sodium-Dependent Glucose Cotransporter-2 Inhibitor Combination Therapy in Type 2 Diabetes. | 2020 | Details |
| A42899 | 33163517 | Hepatobiliary Surg Nutr | The Mediterranean diet and nonalcoholic fatty liver disease in individuals at high cardiovascular risk. | 2020 | Details |
| A42904 | 33149083 | Curr Opin Lipidol | Cardiovascular risk in patients with nonalcoholic fatty liver disease: looking at the liver to shield the heart. | 2020 | Details |
| A42912 | 33123088 | Front Endocrinol (Lausanne) | The Impact of Adipose Tissue-Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer. | 2020 | Details |
| A42913 | 33117357 | Front Immunol | Role of the Nuclear Receptor Corepressor 1 (NCOR1) in Atherosclerosis and Associated Immunometabolic Diseases. | 2020 | Details |
| A42941 | 33023724 | Clin Investig Arterioscler | Control del riesgo cardiovascular, la enfermedad metabólica y la esteatosis hepática a través del empoderamiento de la salud: una propuesta de futuro. | 2021 | Details |
| A42994 | 32869840 | Clin Infect Dis | Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection. | 2021 | Details |
| A43019 | 32797344 | Dig Dis Sci | NAFLD and Statins. | 2020 | Details |
| A43021 | 32795106 | Metab Syndr Relat Disord | Metabolic Syndrome in Children and Adolescents: Is There a Universally Accepted Definition? Does it Matter? | 2020 | Details |
| A43034 | 32755308 | Am J Physiol Gastrointest Liver Physiol | Microbiota on biotics: probiotics, prebiotics, and synbiotics to optimize growth and metabolism. | 2020 | Details |
| A43038 | 32740703 | Acta Diabetol | Nonalcoholic fatty liver disease and cardiovascular risk in severely obese adolescents. | 2020 | Details |
| A43043 | 32714511 | Int J Obes Suppl | From obesity through gut microbiota to cardiovascular diseases: a dangerous journey. | 2020 | Details |
| A43058 | 32687812 | Am J Med | Cardiometabolic Morbidity in Adults With Cerebral Palsy and Spina Bifida. | 2020 | Details |
| A43061 | 32668489 | J Viral Hepat | Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B. | 2020 | Details |
| A43071 | 32637065 | Ther Adv Endocrinol Metab | Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome. | 2020 | Details |